Lung Cancer Surgery Trends and Forecast
The future of the global lung cancer surgery market looks promising with opportunities in the hospital, specialty cancer care center, and ambulatory surgical center markets. The global lung cancer surgery market is expected to reach an estimated $5.7 billion by 2030 with a CAGR of 3.4% from 2024 to 2030. The major drivers for this market are rising occurrence of lung cancer, increasing consumer preference towards minimally invasive surgeries, and increasing air pollution levels.
• Lucintel forecasts that, within the product type category, surgical device is expected to witness the highest growth over the forecast period.
• Within the end use category, ambulatory surgical center is expected to witness the highest growth over the forecast period.
• In terms of regions, North America will remain the largest region over the forecast period.
A more than 150-page report is developed to help in your business decisions.
Emerging Trends in the Lung Cancer Surgery Market
The lung cancer surgery market is evolving rapidly, with many emerging trends reshaping surgical practices and productivity in the operating room. A significant paradigm shift is underway, characterized by advances in surgical techniques and the increasing integration of technology.
• Minimally Invasive Techniques: There is a clear trend toward performing less invasive procedures such as Video-Assisted Thoracoscopic Surgery (VATS) and robotic surgery. These techniques reduce recovery time, minimize pain, and shorten hospital stays, leading to improved patient experiences both emotionally and physically.
• Personalized Surgical Approaches: Surgeons are increasingly tailoring interventions based on individual patient factors, such as genetics and molecular characteristics. This personalized approach enables sequential treatments that enhance therapy outcomes and reduce the risk of adverse events.
• Integration of Technology: The use of advanced technologies like Artificial Intelligence (AI) and augmented reality is improving surgical precision and strategy. These tools assist in detecting tumors and surrounding tissues, which enhances the chances of successful surgery.
• Multidisciplinary Care Models: More hospitals are adopting multidisciplinary care teams for lung cancer treatment, which combines expertise from various medical fields. This approach improves patient outcomes by providing comprehensive care tailored to each individual.
• Increased Research and Funding: There has been a noticeable increase in research and funding aimed at developing new lung cancer treatments. Government and private sector investments are supporting clinical trials to explore innovative surgical techniques for lung cancer treatment.
These emerging trends are transforming the lung cancer surgery market by improving the quality of care and surgical outcomes. The growing emphasis on technology and personalized medicine is driving the development of more effective and patient-centered treatment options.
Recent Developments in the Lung Cancer Surgery Market
Recent developments in the lung cancer surgery market highlight the continuous progress in surgical techniques, technology integration, and patient care.
• Broader Use of Robotic Surgery Systems: The increasing adoption of robotic-assisted surgical systems is giving surgeons greater dexterity and enhanced visualization. This technology allows for minimally invasive surgery, resulting in quicker recovery times and fewer complications for patients.
• Improved Diagnostic and Imaging Techniques: Intraoperative CT and PET scans are becoming integral to surgical planning. These technologies offer real-time imaging, allowing for more precise tumor localization and improved surgical outcomes.
• Telemedicine Utilization: Telemedicine is gaining traction in lung cancer surgery, particularly for preoperative counseling and postoperative follow-ups. This remote care model is especially beneficial for patients in rural or underserved areas, improving access to healthcare and ensuring continuous care.
• Health Awareness Campaigns: Public awareness campaigns about the signs and symptoms of lung cancer are encouraging earlier detection and intervention. As more people seek treatment sooner, the timing of surgeries improves, leading to better overall outcomes.
• International Collaboration and Trials: There has been an increase in international collaborations and clinical trials aimed at improving lung cancer surgery techniques. These initiatives focus on testing new surgical practices and refining existing methods to enhance patient outcomes.
These recent developments are positively impacting the lung cancer surgery market by improving surgical effectiveness, enhancing patient accessibility to care, and advancing research, all of which contribute to better treatment outcomes.
Strategic Growth Opportunities for Lung Cancer Surgery Market
The lung cancer surgery market presents several strategic growth opportunities driven by technological advancements, improved patient care models, and emerging trends in personalized medicine.
• Telehealth Services: Telehealth offers significant growth potential, particularly in the perioperative and postoperative care stages. It allows patients in remote areas to receive consultations, follow-ups, and support, increasing accessibility to surgical care.
• Robotic Surgery Systems: The demand for robotic-assisted surgeries continues to grow, driven by the desire for more precise and minimally invasive procedures. This trend presents an opportunity for manufacturers and hospitals to invest in robotic systems to improve patient outcomes.
• Multidisciplinary Care Models: Establishing multidisciplinary teams that address the comprehensive needs of lung cancer patients presents an opportunity to improve care quality. Hospitals that adopt these models will likely attract more patients seeking holistic, patient-centered care.
• Innovative Surgical Techniques: Advancements in minimally invasive and hybrid surgical techniques offer hospitals an opportunity to enhance their specialization in lung cancer surgery. Hospitals adopting these methods can improve patient outcomes and enhance their institutional reputation.
• Patient Education Programs: There is a growing opportunity to develop and implement patient education programs that raise awareness about early detection and the importance of timely treatment. Educating patients about the need for early diagnosis can help increase the number of surgeries performed and improve treatment success.
These growth opportunities underscore the marketÄX%$%Xs potential to evolve by embracing advanced technologies, personalized treatment plans, and broader patient education efforts. As these trends continue, the lung cancer surgery market is poised for significant expansion.
Lung Cancer Surgery Market Driver and Challenges
Within the lung cancer surgery market, one can find a myriad of drivers and challenges that are likely to satisfy the other market participants. These factors are relevant to those who wish to operate in the market without being frustrated.
The factors responsible for driving the lung cancer surgery market include:
• Rising Incidence of Lung Cancer: The growing number of lung cancer patients worldwide is increasing the demand for surgical interventions. This surge in patient numbers is expanding the market for lung cancer surgeries.
• Technological Advancements: Innovations in surgical technologies, such as advanced imaging systems and robotic surgery, are improving the safety and effectiveness of lung cancer surgeries. These advancements are driving adoption among healthcare providers and attracting more patients seeking improved outcomes.
• Government Initiatives and Institutional Support: Government funding and policy support for cancer research, early diagnosis, and treatment are contributing to the growth of the lung cancer surgery market. These initiatives are improving access to care and enhancing the overall treatment landscape.
• Increased Awareness and Screening: Public education and awareness campaigns are helping individuals recognize the signs and symptoms of lung cancer. Early detection through screening programs is enabling more patients to seek treatment earlier, which improves surgical outcomes.
• Personalized Medicine: The growing trend of personalized cancer treatments is influencing the development of new surgical techniques. Understanding a patientÄX%$%Xs unique characteristics allows for more tailored interventions, improving surgical results and patient satisfaction.
Challenges in the lung cancer surgery market are:
• High Cost of Advanced Technologies: The expense of implementing advanced surgical technologies, such as robotic systems and imaging tools, can be a barrier for some healthcare facilities, limiting access to these technologies in certain regions.
• Legal and Regulatory Barriers: The legal and regulatory processes for introducing new surgical techniques and technologies can be complex and time-consuming, delaying the adoption of innovative treatments in some markets.
• Variations in Medical Training: Disparities in the training and competence of surgeons performing lung cancer surgeries can affect the outcomes and safety of patients. Standardizing training and ensuring continuous education for medical professionals is essential to overcoming this challenge.
Despite these challenges, the lung cancer surgery market continues to grow, driven by advancements in technology, rising awareness, and an increasing focus on patient-centered care.
List of Lung Cancer Surgery Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies lung cancer surgery companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the lung cancer surgery companies profiled in this report include-
• Scanlan International
• Ethicon Endo Surgery
• Covidien
• Trokamed
• Angiodynamics
• Richard Wolf
• BSD Medical
• Siemens Healthcare
• Accuray
• Neomend
Lung Cancer Surgery by Segment
The study includes a forecast for the global lung cancer surgery by product type, surgery, end use, and region.
Lung Cancer Surgery Market by Product Type [Analysis by Value from 2018 to 2030]:
• Surgical Devices
• Endosurgical Equipment
• Monitoring or Visualizing Equipment
Lung Cancer Surgery Market by Surgery [Analysis by Value from 2018 to 2030]:
• Robotic Surgery
• Thoracotomy
• Video Assisted Surgery
• Percutaneous Surgery
• Endobronchial Surgery
Lung Cancer Surgery Market by End Use [Analysis by Value from 2018 to 2030]:
• Hospitals
• Specialty Cancer Care Centers
• Ambulatory Surgical Centers
• Others
Lung Cancer Surgery Market by Region [Analysis by Value from 2018 to 2030]:
• North America
• Europe
• Asia Pacific
• The Rest of the World
Country Wise Outlook for the Lung Cancer Surgery Market
The growth of the lung cancer surgery market is being driven by advancements in technology, increasing incidence rates, and improving treatment protocols. Key countries such as the United States, China, Germany, India, and Japan are leading the way in adopting new surgical technologies and improving patient care.
• United States: The use of robotic-assisted surgery is widespread in the U.S., where it has significantly improved precision and reduced postoperative complications. Advanced imaging systems, such as intraoperative ultrasound and CT, are now commonly used to guide surgeons during lung cancer surgery. Additionally, there is increased funding for research into personalized therapies, which aim to tailor treatments to genetic profiles for more effective outcomes.
• China: China has made significant strides in lung cancer surgery, particularly in urban areas where advanced treatments are becoming more accessible. The government’s investment in healthcare infrastructure and cancer research has improved surgical outcomes. VATS procedures are gaining popularity, and the integration of Traditional Chinese Medicine (TCM) with Western surgical approaches is being explored to improve recovery times.
• Germany: Germany is at the forefront of minimally invasive lung cancer surgery, with hospitals increasingly adopting robotic systems. The countryÄX%$%Xs healthcare system also encourages continuous training for surgeons, ensuring they remain proficient in the latest technologies. Germany is also actively participating in international clinical trials aimed at improving lung cancer treatment practices.
• India: India is focusing on expanding access to advanced lung cancer surgical treatments, particularly in metropolitan areas. Public-private partnerships are helping to increase the availability of minimally invasive surgeries like VATS. Awareness campaigns have encouraged patients to seek surgical treatment at earlier stages, improving surgical outcomes. Telemedicine is also playing a role in facilitating consultations and follow-ups for patients in remote areas.
• Japan: Japan is leading the way in integrating cutting-edge technologies such as augmented reality and AI into lung cancer surgery. These technologies are used for surgical planning and intraoperative navigation, improving precision and reducing risks. Japan’s healthcare system is highly patient-centered, and the country is actively involved in global clinical trials aimed at refining surgical approaches.
Features of the Global Lung Cancer Surgery Market
Market Size Estimates: Lung cancer surgery market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecasts (2024 to 2030) by various segments and regions.
Segmentation Analysis: Lung cancer surgery market size by product type, surgery, end use, and region in terms of value ($B).
Regional Analysis: Lung cancer surgery market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different product types, surgeries, end uses, and regions for the lung cancer surgery market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the lung cancer surgery market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
If you are looking to expand your business in this market or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.
FAQ
Q1. What is the lung cancer surgery market size?
Answer: The global lung cancer surgery market is expected to reach an estimated $5.7 billion by 2030.
Q2. What is the growth forecast for lung cancer surgery market?
Answer: The global lung cancer surgery market is expected to grow with a CAGR of 3.4% from 2024 to 2030.
Q3. What are the major drivers influencing the growth of the lung cancer surgery market?
Answer: The major drivers for this market are rising occurrence of lung cancer, increasing consumer preference towards minimally invasive surgeries, and increasing air pollution levels.
Q4. What are the major segments for lung cancer surgery market?
Answer: The future of the lung cancer surgery market looks promising with opportunities in the hospital, specialty cancer care center, and ambulatory surgical center markets.
Q5. Who are the key lung cancer surgery market companies?
Answer: Some of the key lung cancer surgery companies are as follows:
• Scanlan International
• Ethicon Endo Surgery
• Covidien
• Trokamed
• Angiodynamics
• Richard Wolf
• BSD Medical
• Siemens Healthcare
• Accuray
• Neomend
Q6. Which lung cancer surgery market segment will be the largest in future?
Answer: Lucintel forecasts that surgical device is expected to witness the highest growth over the forecast period.
Q7. In lung cancer surgery market, which region is expected to be the largest in next 6 years?
Answer: North America will remain the largest region over the forecast period.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the lung cancer surgery market by product type (surgical devices, endosurgical equipment, and monitoring or visualizing equipment), surgery (robotic surgery, thoracotomy, video assisted surgery, percutaneous surgery, and endobronchial surgery), end use (hospitals, specialty cancer care centers, ambulatory surgical centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Lung Cancer Surgery Market, Lung Cancer Surgery Market Size, Lung Cancer Surgery Market Growth, Lung Cancer Surgery Market Analysis, Lung Cancer Surgery Market Report, Lung Cancer Surgery Market Share, Lung Cancer Surgery Market Trends, Lung Cancer Surgery Market Forecast, Lung Cancer Surgery Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.